Is predicted to encode a protein with the following domains: Transmembrane Fragile-X-F-associated protein and Transmembrane Fragile-X-F protein. Is an ortholog of C. elegans Y116A8C.9.
Is an ortholog of C. elegans sdc-2. In C. elegans, sdc-2 is involved in dosage compensation by hypoactivation of X chromosome and negative regulation of transcription by RNA polymerase II.
Is an ortholog of C. elegans sdc-2. In C. elegans, sdc-2 is involved in dosage compensation by hypoactivation of X chromosome and negative regulation of transcription by RNA polymerase II.
Is an ortholog of C. elegans dpy-26. In C. elegans, dpy-26 is involved in dosage compensation by hypoactivation of X chromosome; meiotic sister chromatid segregation; and mitotic sister chromatid segregation.
Is an ortholog of C. elegans sdc-2. In C. elegans, sdc-2 is involved in dosage compensation by hypoactivation of X chromosome and negative regulation of transcription by RNA polymerase II.
Predicted to enable DNA binding activity. Is an ortholog of C. elegans baf-1. In C. elegans, baf-1 is involved in several processes, including chromosome segregation; embryo development; and response to X-ray.
Predicted to be involved in spliceosomal tri-snRNP complex assembly. Predicted to be part of U4/U6 x U5 tri-snRNP complex. Is an ortholog of C. elegans prp-31.